Richard Ferrari

Rich is a Co-Founder of De Novo Ventures which has $650 million under management and which is one of the premier firms dedicated to Medical Devices and Bio-Technology. Rich has been a successful CEO of two publicly traded medical technology companies, Cardiovascular Imaging Systems, the first and leading developer of ultrasound imaging catheters, and CardioThoracic Systems (CTS) , which pioneered off-pump bypass surgery. He also co-founded the Medical Technology Group which spun-out Integrated Vascular Systems. Previously Mr. Ferrari held the positions of Executive Vice President and General Manager of ADAC Laboratories. In 1996 he founded Saratoga Ventures, a venture capital partnership that has provided seed financing to startup medical technology companies. Rich is the recipient of the Mallinckrodt Award for Excellence in Medicine and has been a finalist for the Entrepreneur of the Year Award. Rich holds a BS degree from Ashland University and an MBA from the University of South Florida.